These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30548342)

  • 21. Extending the post-thaw viability of cryoprecipitate.
    Thomson C; Sobieraj-Teague M; Scott D; Duncan E; Abraham S; Roxby D
    Transfusion; 2021 May; 61(5):1578-1585. PubMed ID: 33728705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coagulation parameters of ABO group-specific cryosupernatant.
    Gerhard GS; Hoffman SM; Williams EC
    Am J Clin Pathol; 1998 Apr; 109(4):379-86. PubMed ID: 9535389
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High levels of coagulation factors and venous thrombosis risk: strongest association for factor VIII and von Willebrand factor.
    Rietveld IM; Lijfering WM; le Cessie S; Bos MHA; Rosendaal FR; Reitsma PH; Cannegieter SC
    J Thromb Haemost; 2019 Jan; 17(1):99-109. PubMed ID: 30471183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patients with severe von Willebrand disease are insensitive to the releasing effect of DDAVP: evidence that the DDAVP-induced increase in plasma factor VIII is not secondary to the increase in plasma von Willebrand factor.
    Cattaneo M; Simoni L; Gringeri A; Mannucci PM
    Br J Haematol; 1994 Feb; 86(2):333-7. PubMed ID: 8199023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of fibronectin in factor VIII/von Willebrand factor cryoprecipitation.
    Mazurier C; Samor B; Deromeuf C; Goudemand M
    Thromb Res; 1985 Mar; 37(6):651-8. PubMed ID: 3922084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of time of collection and sample processing on von Willebrand factor concentration in retired racing greyhounds.
    Marín LM; Couto CG; Iazbik MC; Westendorf N; Saavedra PV
    J Vet Intern Med; 2008; 22(6):1447-8. PubMed ID: 18976286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Marked von Willebrand factor and factor VIII elevations in severe acute respiratory syndrome coronavirus-2-positive, but not severe acute respiratory syndrome coronavirus-2-negative, pneumonia: a case-control study.
    De Cristofaro R; Liuzzo G; Sacco M; Lancellotti S; Pedicino D; Andreotti F
    Blood Coagul Fibrinolysis; 2021 Jun; 32(4):285-289. PubMed ID: 33443926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What's happening? The quality of methylene blue treated FFP and cryo.
    Seghatchian J; Krailadsiri P
    Transfus Apher Sci; 2001 Dec; 25(3):227-31. PubMed ID: 11846153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Standardization of factor VIII and von Willebrand factor in plasma: calibration of the WHO 5th International Standard (02/150).
    Hubbard AR; Heath AB
    J Thromb Haemost; 2004 Aug; 2(8):1380-4. PubMed ID: 15304044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation between von Willebrand factor antigen, von Willebrand factor ristocetin cofactor activity and factor VIII activity in plasma.
    Lippi G; Franchini M; Salvagno GL; Montagnana M; Poli G; Guidi GC
    J Thromb Thrombolysis; 2008 Oct; 26(2):150-3. PubMed ID: 17786534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ADAMTS13 content in plasma-derived factor VIII/von Willebrand factor concentrates.
    Peyvandi F; Mannucci PM; Valsecchi C; Pontiggia S; Farina C; Retzios AD
    Am J Hematol; 2013 Oct; 88(10):895-8. PubMed ID: 23813910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determinants of factor VIII plasma levels in carriers of haemophilia A and in control women.
    Ay C; Thom K; Abu-Hamdeh F; Horvath B; Quehenberger P; Male C; Mannhalter C; Pabinger I
    Haemophilia; 2010 Jan; 16(1):111-7. PubMed ID: 19758307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Von Willebrand factor/factor VIII concentrates in the treatment of von Willebrand disease.
    Batlle J; López-Fernández MF; Fraga EL; Trillo AR; Pérez-Rodríguez MA
    Blood Coagul Fibrinolysis; 2009 Mar; 20(2):89-100. PubMed ID: 19786936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cryoprecipitate production: the use of additives to enhance the yield.
    Yousef H; Neurath D; Freedman M; Rock G
    Clin Lab Haematol; 2006 Aug; 28(4):237-40. PubMed ID: 16898961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cryoprecipitate prepared from plasma treated with methylene blue plus light: increasing the fibrinogen concentration.
    Hornsey VS; Young DA; Docherty A; Hughes W; Prowse CV
    Transfus Med; 2004 Oct; 14(5):369-74. PubMed ID: 15500456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of von Willebrand disease with factor VIII/von Willebrand factor concentrates: results from current studies and surveys.
    Federici AB
    Blood Coagul Fibrinolysis; 2005 Apr; 16 Suppl 1():S17-21. PubMed ID: 15849522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postfiltration factor VIII and fibrinogen levels in cryoprecipitate stored at room temperature and at 1 to 6 degrees C.
    Spivey MA; Jeter EK; Lazarchick J; Kizer J; Spivey LB
    Transfusion; 1992 May; 32(4):340-3. PubMed ID: 1585439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ADAMTS-13 activity and von Willebrand factor levels in methylene-blue photo-inactivated plasma processed by either the Springe method or an 'in house' system.
    del Río-Garma J; Pereira A; Arroyo JL; Mateo J; Alvarez-Larrán A; Martínez C; Muncunill J; Barbolla L;
    Vox Sang; 2008 Aug; 95(2):101-5. PubMed ID: 18557825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteomic characterization of plasma-derived clotting factor VIII-von Willebrand factor concentrates.
    Clifton JG; Huang F; Kovac S; Yang X; Hixson DC; Josic D
    Electrophoresis; 2009 Oct; 30(20):3636-46. PubMed ID: 19768705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. von Willebrand factor contained in factor VIII concentrates of different purities supports platelet adhesion in blood samples from a heterogeneous group of patients with von Willebrand disease.
    Escolar G; Carretero M; Magallón M; Quintana M; Arnau C; Castillo R; Aznar-Salatti J
    Haematologica; 1998 Nov; 83(11):1009-14. PubMed ID: 9864923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.